Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein

Y Hosohata1, E V Varga, D Stropova

  • 1Department of Pharmacology, The University of Arizona, Tucson 85724, USA.

Life Sciences
|May 19, 2001
PubMed

Insights

This study reveals how mutations in the human delta opioid receptor (hDOR) affect the binding and activity of different opioid agonists. Understanding these interactions is key to developing targeted pain relief medications.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • The delta opioid receptor (DOR) plays a crucial role in pain modulation and other physiological processes.
  • Understanding the structure-activity relationships of DOR agonists is essential for developing selective therapeutics.
  • Previous studies have explored various mutations affecting receptor function, but specific conformational changes remain to be elucidated.

Purpose of the Study:

  • To investigate the impact of the W284L mutation in the human delta opioid receptor (hDOR) on the binding affinities and intrinsic activities of various delta opioid agonists.
  • To determine if different chemical classes of delta opioid agonists utilize distinct receptor conformations for G protein activation.

Main Methods:

  • Utilized a [35S]GTPgammaS binding assay to measure the intrinsic activities of delta opioid agonists.
  • Employed Chinese hamster ovary (CHO) cells stably expressing either wild-type hDOR (hDOR/CHO) or the W284L mutant hDOR (W284L/CHO).
  • Assessed agonist binding affinities in the presence and absence of sodium and guanine nucleotides.

Main Results:

  • The W284L mutation differentially affected agonist binding affinities and intrinsic activities, with SNC 80 showing reduced affinity but higher maximal stimulation.
  • Agonist binding affinities were more robustly regulated by sodium and guanine nucleotide in the W284L mutant compared to wild-type receptors.
  • Different chemical classes of delta opioid agonists exhibited distinct responses to the W284L mutation, suggesting class-specific conformational states.

Conclusions:

  • The W284L mutation in hDOR alters receptor function, impacting the affinity and efficacy of various delta opioid agonists.
  • The findings support the hypothesis that delta opioid agonists of different chemical classes adopt specific conformations to activate G proteins.
  • This research provides valuable insights into the conformational dynamics of the delta opioid receptor and its interactions with diverse agonists.

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...